InsightRX
Total Raised
$13.64MInvestors Count
18Funding, Valuation & Revenue
13 Fundings
InsightRX has raised $13.64M over 13 rounds.
InsightRX's latest funding round was a Loan for on February 24, 2024.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
2/24/2024 | Loan | 2 | ||||
10/4/2021 | Incubator/Accelerator - V | 1 | ||||
10/15/2020 | Incubator/Accelerator - IV | 1 | ||||
9/19/2019 | Series A - II | |||||
6/6/2018 | Biz Plan Competition |
Date | 2/24/2024 | 10/4/2021 | 10/15/2020 | 9/19/2019 | 6/6/2018 |
|---|---|---|---|---|---|
Round | Loan | Incubator/Accelerator - V | Incubator/Accelerator - IV | Series A - II | Biz Plan Competition |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 2 | 1 | 1 |
InsightRX Investors
18 Investors
InsightRX has 18 investors. CIBC Innovation Banking invested in InsightRX's Loan funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
2/24/2024 | 2/24/2024 | 1 Loan | Diversified Financial Services | |||
10/4/2021 | 10/4/2021 | 1 Incubator/Accelerator - V | Incubator/Accelerator | New York | ||
4/14/2015 | 10/15/2020 | 2 Seed, Incubator/Accelerator - IV (2020) | Incubator/Accelerator | |||
Venture Capital | California | |||||
Venture Capital | California |
First funding | 2/24/2024 | 10/4/2021 | 4/14/2015 | ||
|---|---|---|---|---|---|
Last Funding | 2/24/2024 | 10/4/2021 | 10/15/2020 | ||
Investor | |||||
Rounds | 1 Loan | 1 Incubator/Accelerator - V | 2 Seed, Incubator/Accelerator - IV (2020) | ||
Board Seats | |||||
Type | Diversified Financial Services | Incubator/Accelerator | Incubator/Accelerator | Venture Capital | Venture Capital |
Location | New York | California | California |
Compare InsightRX to Competitors
Rx Studio operates within the healthcare technology sector, offering a platform that provides clinical decision support through pharmacogenomic and pharmacometric recommendations for drug dosing. The company serves clinical decision makers including pharmacists, pharmacologists, and physicians, with an emphasis on patient care and integration with electronic health records. It was founded in 2020 and is based in Walnut, California.
PrecisePK provides therapeutic drug monitoring software that focuses on Bayesian model-informed precision dosing for the medical and pharmaceutical industries. The company offers a software platform that delivers individualized dosing recommendations, using Bayesian algorithms to account for complex patient cases and generate predictive models, graphical visualizations, and analytics. PrecisePK's clientele includes healthcare institutions and clinical pharmacists interested in dosage management. It was founded in 1986 and is based in San Diego, California.
DoseMeRx develops a software-based precision dosing tool designed to help clinicians dose a patient based on the patient's ability to absorb. Its software-based precision dosing tool uses patients' information such as height, weight, and gender and accurately calculates dosage to suit an individual patient. The company was founded in 2014 and is based in Jupiter, Florida. In January 2023, DoseMeRx was acquired by Fairlong Capital. The terms of the transaction were not disclosed.
ExactCure focuses on personalized health solutions within the healthcare industry. It offers a software solution that helps simulate the effectiveness and interactions of drugs in a patient's body based on their characteristics. This solution primarily serves the healthcare industry. The company was founded in 2018 and is based in Nice, France. In April 2024, ExactCure merged with Quantum Genomics.
Loading...